Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD in Hand Osteoarthritis and Psoriatic Arthritis
NCT03693833Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Nov 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in osteoarthritis (OA) and psoriatic arthritis (PsA) (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Visual Analogue Scale Pain at 12 weeks. Started Nov 2018; status: completed.
02
Drugs
cannabidiol
03
Conditions
osteoarthritis (OA)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT03693833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03693833.